Glass half empty is probably the best outlook!3 Apr 2025 07:31
So Amala Foods is allegedly progressing with a reverse takeover of Dialysis Care Plus Inc, a start up company focused on building dialysis centers in the Philippines. Its strategy to tap into the growing healthcare dialysis services sector in the country.
To date all we know is that Dialysis Care Plus is a healthcare company based in the Philippines and currently there is no publicly available financial information on this company.
However it needs to be noted that there are already several companies that are major players dialysis services sector like NephroPlus, Fresenius Medical Care, B. Braun Melsungen AG, Baxter International Inc., and Diaverum that dominate the industry and have been expanding rapidly, securing significant investments and increasing their presence in multiple regions of the Philippines. The Filipino dialysis market is experiencing steady growth, driven by the increasing prevalence of chronic kidney disease and improvements in healthcare infrastructure. The market is expected to grow at a compound annual growth rate of 4.2% from 2025 to 2034.
Dialysis Care Plus Inc is a relatively small new player in this market and will likely struggle to take market share from the major players. It will need to look at alternative markets such as home dialysis innovations and AI-driven patient monitoring otherwise they will struggle against larger competitors.
Dialysis Care Plus Inc faces significant challenges as a new entrant in the highly competitive Filipino dialysis market as established players dominate the industry, benefiting from strong brand recognition, advanced technology, and extensive networks.
However, Dialysis Care Plus could still carve out a niche if it focuses on low cost dialysis solutions and secures strategic investment partnerships, as always with new start-ups time and monetary generation are the biggest obstacles to success.
It seems to me that the inept BOD have backed the wrong horse again at shareholders expense, and I very much doubt (if this actually comes to fruition) there will be any positive share price movement until the market sees sustainable organic and fiscal growth as well as expansion through mergers and acquisition.